SCHEMBL31728124

SCHEMBL31728124

COCCn1cnc(C(=O)OC)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.43
ADRB3 P13945 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 6/20 0.36
GLA P06280 6/20 0.36
GAA P10253 6/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 5/20 0.36
CASP1 P29466 4/20 0.36
CASP7 P55210 4/20 0.36
ATM Q13315 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
THRB P10828 1/20 0.35
RUNX1 Q01196 1/20 0.35
CBFB Q13951 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6854963 0.86 NOTUM (0.40) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL15199612 0.85 ADRB3 (0.44) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL24842047 0.85 ADRB3 (0.40) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL6853830 0.85 NOTUM (0.39) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL4672515 0.83 NOTUM (0.44) NOTUMADRB3TMEM97HRH3SMN1; SMN2
SCHEMBL6855523 0.83 TSHR (0.39) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL21281675 0.83 NOTUM (0.42) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL4784720 0.81 NOTUM (0.46) NOTUMADRB3TMEM97HRH3ALDH1A1
SCHEMBL7464070 0.81 ADRB3 (0.46) NOTUMADRB3TMEM97HRH3SMN1; SMN2
SCHEMBL24841515 0.80 ADRB3 (0.41) NOTUMADRB3TMEM97HRH3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 WO disclosed